Myogenica Inc.
Biotechnology company · Saint Paul, Minnesota, United States
Myogenica Inc. is a biotechnology company headquartered in Saint Paul, Minnesota, United States. Its earliest recorded incorporation is in 2021. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $1.6 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $100,000 sold in a notice filed in 2022.
Myogenica at a glance
What does Myogenica do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $1.6 million in total (2023 to 2025). NIH funding came from the National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $100,000 sold (2022).
Frequently asked questions about Myogenica
Where is Myogenica headquartered?
Myogenica Inc. is headquartered in Saint Paul, Minnesota, United States.
What does Myogenica do?
Myogenica Inc. is a biotechnology company.
When was Myogenica founded?
The earliest incorporation on record for Myogenica Inc. is in 2021, according to public company registers.
Similar companies
- Agitated Solutions, Inc.Saint Paul, Minnesota, United States
- Astrin Biosciences, Inc.Saint Paul, Minnesota, United States
- EyeMacular Regeneration, Inc.Saint Paul, Minnesota, United States
- B-MoGen Biotechnologies, Inc.Saint Paul, Minnesota, United States
- Aria CV, Inc.Saint Paul, Minnesota, United States
- Innovative Surface Technologies IncSaint Paul, Minnesota, United States
- Quench Medical Inc.Saint Paul, Minnesota, United States
- Marpam Pharma LLCSaint Paul, Minnesota, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences